Expert insights. Personalized for you.
The cover for issue 31 of Oncotarget features Figure 4, ‘Concentration dose-response curves of sirolimus effect [55 nM-1 nM] on the number of cells per surviving colony in U2OS cell line after 2 weeks exposure,’ by Vasuri, et al. MORE
Antibody-like proteins that capture and neutralize SARS-CoV-2 Scientists have used a new high-speed, in vitro selection method to isolate 9 antibody-like proteins (ALPs) that bind to the SARS-CoV-2 virus – 4 of which also exhibited neutralizing activity – within 4 days, according to a new study. MORE
Supports rapid molecular detection of acute HIV infection, which is critical in curbing further disease transmission. Food and Drug Administration (FDA) approval for the cobas® HIV-1/HIV-2 Qualitative Test for use on the fully automated cobas® 6800/8800 Systems in the U.S. MORE
Cross-reactive neutralization of SARS-CoV-2 by serum antibodies from recovered SARS patients and immunized animals Antibodies in serum samples collected from patients infected with SARS-CoV during the 2003 outbreak effectively neutralized SARS-CoV-2 infection in cultured cells, according to a new study. MORE
BILLERICA, Mass.–(BUSINESS MORE
The new Elecsys Anti-SARS-CoV-2 S test can quantitatively measure the level of antibodies against SARS-CoV-2 in patients who have been exposed to the virus. This is the focus of vaccines in development and convalescent plasma therapy. In 2019, Roche invested CHF 11.7 MORE
DUBLIN–(BUSINESS WIRE)–The “2020 Three Scenarios of the Future In Vitro Diagnostics Market: Business-as-Usual, Economic Austerity, Technological Breakthroughs” report has been added to ResearchAndMarkets.com’s offering. MORE
This test is also available in markets accepting the CE mark. This test is intended for the simultaneous qualitative detection and differentiation of SARS-CoV-2, Influenza A and Influenza B in patients suspected by their healthcare provider of having respiratory viral infection consistent with COVID-19. Additionally, it is available in markets accepting the CE mark. Multiplexing will increase lab efficiency and save resources in the labs. In the U.S., MORE
The project seeks to kickstart the development of an open access “Organoid Cell Atlas” By creating well-characterized in vitro […]. MORE
Industry body says in vitro diagnostics are vital to clearing the backlog of undiagnosed conditions. BIVDA has suggest focusing on three key areas – innovation, manufacturing and people – to support and strengthen the IVD industry in the short- and long-term future. MORE
–(BUSINESS WIRE)–THIS RELEASE DISCUSSES INVESTIGATIONAL USES OF BETADINE AND IS NOT INTENDED TO CONVEY CONCLUSIONS ABOUT ITS EFFICACY OR SAFETY IN TREATING AND/OR PREVENTING COVID-19 OR ANY OTHER VIRUSES. STAMFORD, Conn.–(BUSINESS BETADINE ANTISEPTIC PRODUCTS HAVE NOT BEEN DEMONSTRATED TO BE … Continue reading → Business Wire MORE
Eurobio Scientific launches a first rapid diagnostic test for the detection of the SARS CoV-2 virus antigen Paris, September 22, 2020 –6:00 pm Eurobio Scientific (FR0013240934, ALERS, PEA-PME eligible), a leading French group in in vitro medical diagnostics and life … Continue reading → GlobeNewswire MORE
40 A company that has developed a digital treatment for pain and anxiety – Belgium-based Oncomfort – has raised €10 million in first-round financing that will be used to fund international growth. MORE
Credit: Bat-science.com New research by BAT indicates that modern oral products (MOPs) showed lower toxicity responses in certain assays than traditional cigarettes. MORE
Shionogi has announced the launch of its new antibiotic in the UK for the treatment of infections due to aerobic Gram-negative bacteria in patients over 18 with limited treatment options. . Photo by hiromitsu morimoto. MORE
Over the past few years, 3D Cell Culture has gained momentum within the pharmaceutical industry due to the benefits that this model offers for in vitro applications patient-derived tissues, drug discovery, predictivity and validation, and safety and toxicity. MORE
DUBLIN–(BUSINESS WIRE)–The “Diabetes Assays (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 market impact)” report has been added to ResearchAndMarkets.com’s offering. This market model discusses in detail the impact of COVID-19 on Diabetes Assays market for the … Continue reading → Business Wire MORE
M€Strengthening of financial resources Continuation of momentum expected during second half of the year Paris, October 15, 2020 – 5:35 pm Eurobio Scientific (FR0013240934, ALERS, PEA-PME eligible), a leading French group in in vitro … Continue reading → GlobeNewswire2020 HALF-YEAR RESULTS EBITDA reaches 20.3 MORE
40 
OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection … Continue reading → GlobeNewswireNEW YORK, NY, REHOVOT, Israel, and SINGAPORE, Sept. 22, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical Ltd. MORE
Eurobio Scientific announces the CE marking of its COVID EBX FluCoSyn™ PCR test Paris, September 15, 2020 –5:45 pm Eurobio Scientific (FR0013240934, ALERS, eligible PEA-PME), a leading French group in the field of specialty in vitro medical diagnostics, announces today … Continue reading → GlobeNewswire MORE
40 
Draper, in one of the latest lab-on-a-chip advances, has shown that its dynamic, in vitro tumor microenvironment can be used to distinguish tumor responses against two different checkpoint inhibitors in three mouse lines MORE
Developed by Resolution Medical, an in vitro diagnostic and medical device manufacturer, the innovative 3D-printed sterile swab is … Continue reading → Business WireRONKONKOMA, N.Y.–(BUSINESS –(BUSINESS WIRE)–#3D–Qosina is pleased to announce they now carry a sterile 3D-printed nasopharyngeal COVID-19 testing swab for nasal mucosa specimen collection. MORE
The test is FDA-approved to report short variants in 311 genes including rearrangements and copy number losses in BRCA1 and BRCA2 genes. The results are delivered in an integrated report that identifies alterations matched to FDA-approved therapies. MORE
In the first stage in the partnership, the companies will use KidneyIntelX, an artificial intelligence-enabled in vitro diagnostic platform, to look at further improving outcomes for patients with chronic kidney disease (CKD) and its complications, in coordination with the Mount Sinai Health System. MORE
– Antiviral Activity Confirmed by Early Stage Studies Conducted through the National Institute of Allergy and Infectious Diseases Preclinical Services Program and Texas Biomedical Research Institute – Patient Enrollment for Phase 2 Trial Ongoing DALLAS, Texas, Oct. 07, 2020 (GLOBE … Continue reading → GlobeNewswire MORE
This week’s round up features a digital solution for adapting clinical trials to ease the burden on the clinical research industry and an in vitro model that mimics the human airway epithelium using a newly developed technology platform. MORE
(Boston)– Responding to the COVID-19 pandemic caused by the novel coronavirus, SARS-CoV-2, requires models that can duplicate disease development in humans, identify potential targets and enable drug testing. Specifically, access to primary human lung in vitro model systems is a priority since a variety of respiratory epithelial cells are the proposed targets of viral entry. […]. MORE
Freshly isolated human chondrocytes exhibit a natural, biologically relevant phenotype during in vitro expansion MORE
Presentations to showcase in vitro activity of ibrexafungerp against fluconazole-susceptible and -resistant Candida spp. and clinical data from VANISH-303 PHASE 3 trial evaluating ibrexafungerp as a treatment for vaginal yeast infections JERSEY CITY, N.J., 12, 2020 (GLOBE NEWSWIRE) — … Continue reading → GlobeNewswire MORE
This filing is the last part of a rolling submission with the FDA that the company began in early April and could lead to a full licence for the drug, which was the first to show significant improvements in recovery time in patients with severe disease. MORE
OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early … Continue reading → GlobeNewswireNEW YORK, NY, ISRAEL, and SINGAPORE, Sept. 02, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Todos Medical Ltd. MORE
OTCQB: TOMDF), an in vitro diagnostics company focused on distributing … Continue reading → GlobeNewswire– Initial Investment of $275,000 followed by up to $10 Million commitment over 24-months REHOVOT, Israel, SINGAPORE and NEW YORK, Aug. 10, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Todos Medical Ltd. MORE
40 
Antigen test reliably and quickly triages people suspected of SARS-CoV-2, with results ready in 15 minutes, allowing informed treatment decisions. The SARS-CoV-2 Rapid Antigen Test is for use in point of care settings for both symptomatic and asymptomatic people. MORE
Brilacidin and Remdesivir shown to act synergistically in vitro, increasing overall inhibition against the novel coronavirus to 99.85 percent in a human lung cell line Data suggest that Brilacidin and Remdesivir, with different but complementary primary mechanisms of action, may … Continue reading → GlobeNewswire MORE
40 18, 2020) – Success rates for in vitro fertilization are higher at clinics that voluntarily share more information than required by government regulators, according to new research by faculty at the University of Colorado School of Medicine. In a review of data reported between 2014 and 2017, CU researchers found that clinics […]. AURORA, Colo. MORE
The two studies were recently published online in the journal Science, both of which were led by Jean-Laurent Casanova, an infectious disease geneticist at Rockefeller University. Related: Low T Cell Counts Observed in COVID-19 Patients. Mutational Errors in COVID-19 Patients. MORE
LONDON–(BUSINESS WIRE)–#healthcareindustry–Advancements in technology, customers’ changing expectations, and increasing investment in the healthcare industry have influenced significant growth in the in-vitro diagnostics market. MORE
SMi’s 3rd Annual Pharmaceutical Microbiology Conference will no longer take place in Boston. She served as the Deputy Director (Acting) in the Office of Process and Facilities (OPF)/OPQ/CDER, responsible for new, generic, and biologic drug product quality review and facility assessment. MORE
– Lead product candidate, SB206 currently being evaluated in B-SIMPLE4 pivotal Phase 3 study in molluscum contagiosum with topline data targeted for Q2 2021 – – In vitro assessments of ability of NITRICIL™ to inhibit the replication mechanisms of SARS-COV-2 … Continue reading → GlobeNewswire MORE
In-Vitro Related Topics Scienmag
OCTOBER 20, 2020
The cover for issue 31 of Oncotarget features Figure 4, ‘Concentration dose-response curves of sirolimus effect [55 nM-1 nM] on the number of cells per surviving colony in U2OS cell line after 2 weeks exposure,’ by Vasuri, et al.
BioTech 365
SEPTEMBER 7, 2020
LONDON–(BUSINESS WIRE)–#healthcareindustry–Advancements in technology, customers’ changing expectations, and increasing investment in the healthcare industry have influenced significant growth in the in-vitro diagnostics market.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
BioTech 365
OCTOBER 8, 2020
DUBLIN–(BUSINESS WIRE)–The “2020 Three Scenarios of the Future In Vitro Diagnostics Market: Business-as-Usual, Economic Austerity, Technological Breakthroughs” report has been added to ResearchAndMarkets.com’s offering.
The Pharma Data
OCTOBER 16, 2020
This week’s round up features a digital solution for adapting clinical trials to ease the burden on the clinical research industry and an in vitro model that mimics the human airway epithelium using a newly developed technology platform.
Scienmag
OCTOBER 9, 2020
Cross-reactive neutralization of SARS-CoV-2 by serum antibodies from recovered SARS patients and immunized animals Antibodies in serum samples collected from patients infected with SARS-CoV during the 2003 outbreak effectively neutralized SARS-CoV-2 infection in cultured cells, according to a new study.
BioTech 365
OCTOBER 7, 2020
– Antiviral Activity Confirmed by Early Stage Studies Conducted through the National Institute of Allergy and Infectious Diseases Preclinical Services Program and Texas Biomedical Research Institute – Patient Enrollment for Phase 2 Trial Ongoing DALLAS, Texas, Oct. 07, 2020 (GLOBE … Continue reading → GlobeNewswire
BioTech 365
AUGUST 13, 2020
–(BUSINESS WIRE)–THIS RELEASE DISCUSSES INVESTIGATIONAL USES OF BETADINE AND IS NOT INTENDED TO CONVEY CONCLUSIONS ABOUT ITS EFFICACY OR SAFETY IN TREATING AND/OR PREVENTING COVID-19 OR ANY OTHER VIRUSES. STAMFORD, Conn.–(BUSINESS BETADINE ANTISEPTIC PRODUCTS HAVE NOT BEEN DEMONSTRATED TO BE … Continue reading → Business Wire
Pharma Times
SEPTEMBER 17, 2020
Industry body says in vitro diagnostics are vital to clearing the backlog of undiagnosed conditions
BioSpace
SEPTEMBER 29, 2020
Draper, in one of the latest lab-on-a-chip advances, has shown that its dynamic, in vitro tumor microenvironment can be used to distinguish tumor responses against two different checkpoint inhibitors in three mouse lines
Drug Discovery Today
APRIL 15, 2020
Freshly isolated human chondrocytes exhibit a natural, biologically relevant phenotype during in vitro expansion
Scienmag
OCTOBER 18, 2020
18, 2020) – Success rates for in vitro fertilization are higher at clinics that voluntarily share more information than required by government regulators, according to new research by faculty at the University of Colorado School of Medicine. In a review of data reported between 2014 and 2017, CU researchers found that clinics […]. AURORA, Colo.
Scienmag
SEPTEMBER 28, 2020
Credit: Bat-science.com New research by BAT indicates that modern oral products (MOPs) showed lower toxicity responses in certain assays than traditional cigarettes.
BioTech 365
OCTOBER 15, 2020
M€Strengthening of financial resources Continuation of momentum expected during second half of the year Paris, October 15, 2020 – 5:35 pm Eurobio Scientific (FR0013240934, ALERS, PEA-PME eligible), a leading French group in in vitro … Continue reading → GlobeNewswire2020 HALF-YEAR RESULTS EBITDA reaches 20.3
BioTech 365
OCTOBER 12, 2020
Presentations to showcase in vitro activity of ibrexafungerp against fluconazole-susceptible and -resistant Candida spp. and clinical data from VANISH-303 PHASE 3 trial evaluating ibrexafungerp as a treatment for vaginal yeast infections JERSEY CITY, N.J., 12, 2020 (GLOBE NEWSWIRE) — … Continue reading → GlobeNewswire
BioTech 365
OCTOBER 6, 2020
Developed by Resolution Medical, an in vitro diagnostic and medical device manufacturer, the innovative 3D-printed sterile swab is … Continue reading → Business WireRONKONKOMA, N.Y.–(BUSINESS –(BUSINESS WIRE)–#3D–Qosina is pleased to announce they now carry a sterile 3D-printed nasopharyngeal COVID-19 testing swab for nasal mucosa specimen collection.
BioTech 365
SEPTEMBER 22, 2020
Eurobio Scientific launches a first rapid diagnostic test for the detection of the SARS CoV-2 virus antigen Paris, September 22, 2020 –6:00 pm Eurobio Scientific (FR0013240934, ALERS, PEA-PME eligible), a leading French group in in vitro medical diagnostics and life … Continue reading → GlobeNewswire
BioTech 365
SEPTEMBER 22, 2020
OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection … Continue reading → GlobeNewswireNEW YORK, NY, REHOVOT, Israel, and SINGAPORE, Sept. 22, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical Ltd.
Scienmag
AUGUST 31, 2020
The project seeks to kickstart the development of an open access “Organoid Cell Atlas” By creating well-characterized in vitro […].
BioTech 365
SEPTEMBER 15, 2020
Eurobio Scientific announces the CE marking of its COVID EBX FluCoSyn™ PCR test Paris, September 15, 2020 –5:45 pm Eurobio Scientific (FR0013240934, ALERS, eligible PEA-PME), a leading French group in the field of specialty in vitro medical diagnostics, announces today … Continue reading → GlobeNewswire
BioTech 365
SEPTEMBER 15, 2020
Brilacidin and Remdesivir shown to act synergistically in vitro, increasing overall inhibition against the novel coronavirus to 99.85 percent in a human lung cell line Data suggest that Brilacidin and Remdesivir, with different but complementary primary mechanisms of action, may … Continue reading → GlobeNewswire
BioTech 365
SEPTEMBER 14, 2020
– Lead product candidate, SB206 currently being evaluated in B-SIMPLE4 pivotal Phase 3 study in molluscum contagiosum with topline data targeted for Q2 2021 – – In vitro assessments of ability of NITRICIL™ to inhibit the replication mechanisms of SARS-COV-2 … Continue reading → GlobeNewswire
BioTech 365
SEPTEMBER 2, 2020
OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early … Continue reading → GlobeNewswireNEW YORK, NY, ISRAEL, and SINGAPORE, Sept. 02, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Todos Medical Ltd.
Scienmag
SEPTEMBER 21, 2020
(Boston)– Responding to the COVID-19 pandemic caused by the novel coronavirus, SARS-CoV-2, requires models that can duplicate disease development in humans, identify potential targets and enable drug testing. Specifically, access to primary human lung in vitro model systems is a priority since a variety of respiratory epithelial cells are the proposed targets of viral entry. […].
BioTech 365
AUGUST 12, 2020
DUBLIN–(BUSINESS WIRE)–The “Diabetes Assays (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 market impact)” report has been added to ResearchAndMarkets.com’s offering. This market model discusses in detail the impact of COVID-19 on Diabetes Assays market for the … Continue reading → Business Wire
BioTech 365
AUGUST 10, 2020
OTCQB: TOMDF), an in vitro diagnostics company focused on distributing … Continue reading → GlobeNewswire– Initial Investment of $275,000 followed by up to $10 Million commitment over 24-months REHOVOT, Israel, SINGAPORE and NEW YORK, Aug. 10, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Todos Medical Ltd.
Scienmag
SEPTEMBER 18, 2020
Antibody-like proteins that capture and neutralize SARS-CoV-2 Scientists have used a new high-speed, in vitro selection method to isolate 9 antibody-like proteins (ALPs) that bind to the SARS-CoV-2 virus – 4 of which also exhibited neutralizing activity – within 4 days, according to a new study.
The Pharma Data
SEPTEMBER 17, 2020
Industry body says in vitro diagnostics are vital to clearing the backlog of undiagnosed conditions. BIVDA has suggest focusing on three key areas – innovation, manufacturing and people – to support and strengthen the IVD industry in the short- and long-term future.
The Pharma Data
AUGUST 24, 2020
In the first stage in the partnership, the companies will use KidneyIntelX, an artificial intelligence-enabled in vitro diagnostic platform, to look at further improving outcomes for patients with chronic kidney disease (CKD) and its complications, in coordination with the Mount Sinai Health System.
Pharma Phorum
OCTOBER 12, 2020
Over the past few years, 3D Cell Culture has gained momentum within the pharmaceutical industry due to the benefits that this model offers for in vitro applications patient-derived tissues, drug discovery, predictivity and validation, and safety and toxicity.
The Pharma Data
SEPTEMBER 15, 2020
Shionogi has announced the launch of its new antibiotic in the UK for the treatment of infections due to aerobic Gram-negative bacteria in patients over 18 with limited treatment options. . Photo by hiromitsu morimoto.
Pharma Phorum
SEPTEMBER 9, 2020
A company that has developed a digital treatment for pain and anxiety – Belgium-based Oncomfort – has raised €10 million in first-round financing that will be used to fund international growth.
Pharma Phorum
AUGUST 10, 2020
This filing is the last part of a rolling submission with the FDA that the company began in early April and could lead to a full licence for the drug, which was the first to show significant improvements in recovery time in patients with severe disease.
The Pharma Data
AUGUST 31, 2020
Supports rapid molecular detection of acute HIV infection, which is critical in curbing further disease transmission. Food and Drug Administration (FDA) approval for the cobas® HIV-1/HIV-2 Qualitative Test for use on the fully automated cobas® 6800/8800 Systems in the U.S.
The Pharma Data
SEPTEMBER 17, 2020
The new Elecsys Anti-SARS-CoV-2 S test can quantitatively measure the level of antibodies against SARS-CoV-2 in patients who have been exposed to the virus. This is the focus of vaccines in development and convalescent plasma therapy. In 2019, Roche invested CHF 11.7
The Pharma Data
SEPTEMBER 1, 2020
Antigen test reliably and quickly triages people suspected of SARS-CoV-2, with results ready in 15 minutes, allowing informed treatment decisions. The SARS-CoV-2 Rapid Antigen Test is for use in point of care settings for both symptomatic and asymptomatic people.
The Pharma Data
AUGUST 27, 2020
The test is FDA-approved to report short variants in 311 genes including rearrangements and copy number losses in BRCA1 and BRCA2 genes. The results are delivered in an integrated report that identifies alterations matched to FDA-approved therapies.
Pharma Phorum
AUGUST 24, 2020
SMi’s 3rd Annual Pharmaceutical Microbiology Conference will no longer take place in Boston. She served as the Deputy Director (Acting) in the Office of Process and Facilities (OPF)/OPQ/CDER, responsible for new, generic, and biologic drug product quality review and facility assessment.
The Pharma Data
SEPTEMBER 3, 2020
This test is also available in markets accepting the CE mark. This test is intended for the simultaneous qualitative detection and differentiation of SARS-CoV-2, Influenza A and Influenza B in patients suspected by their healthcare provider of having respiratory viral infection consistent with COVID-19. Additionally, it is available in markets accepting the CE mark. Multiplexing will increase lab efficiency and save resources in the labs. In the U.S.,
XTalks
SEPTEMBER 30, 2020
The two studies were recently published online in the journal Science, both of which were led by Jean-Laurent Casanova, an infectious disease geneticist at Rockefeller University. Related: Low T Cell Counts Observed in COVID-19 Patients. Mutational Errors in COVID-19 Patients.
Let's personalize your content